![](/img/cover-not-exists.png)
Response to “Rates of Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A Treated with Plasma-Derived or Recombinant Factor VIII: No Proof of Difference or Proof of No Difference?”
Franchini, Massimo, Mengoli, CarloVolume:
40
Language:
english
Journal:
Seminars in Thrombosis and Hemostasis
DOI:
10.1055/s-0034-1367472
Date:
February, 2014
File:
PDF, 67 KB
english, 2014